Newest
PEBO ▼ sold $76K · Augenstein Mark filed 1d agoBBT ▲ bought $105K · Hollister Thomas J filed 2d agoBBT ▼ sold $20K · Eagan John Buckley filed 2d agoGS ▼ sold $60K · LESLIE ERICKA T filed 2d agoGS ▼ sold $163K · LESLIE ERICKA T filed 2d agoMSCI ▼ sold $1.5M · Gutowski Robert J. filed 2d agoGL ▼ sold $2.2M · MAJORS MICHAEL CLAY filed 2d agoPHR ▲ bought $362 · Linetsky David filed 2d agoPHR ▲ bought $320 · Linetsky David filed 2d agoRVI ▲ bought $23K · Whitney Meredith filed 2d agoLEO ▲ bought $369K · Saba Capital Management, L.P. filed 2d agoPG ▼ sold $5.7M · Jejurikar Shailesh filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoICLR ▼ sold $15K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoPG ▼ sold $698K · Gama Paul filed 2d ago

Company / CIK 0001919246

Pelthos Therapeutics Inc.

Ticker
PTHS
Size, estimated from filings
Micro cap (under $300M)
Insiders on file
8
Federal contracts on record
none matched
Lobbying filings on record
none matched
SEC filings
EDGAR ↗
Latest trade on record
October 2, 2026

Pelthos Therapeutics Inc. (PTHS) has 8 insiders on file who disclosed 39 transactions in the last 12 months (2 open-market buys, 26 sales, about $1.5M at reported prices). No federal contract award that started in the last 180 days was found for a recipient with exactly this name; no lobbying filing names it as client this year.

Last updated October 6, 2026 · Sources: SEC EDGAR; USAspending; Senate LDA

Pelthos Therapeutics Inc. in charts

Who is trading this stock

Which people account for the buying and selling over the last 12 months?

BoughtSold

6 people account for the disclosed buying and selling in Pelthos Therapeutics Inc. over the last 12 months; the most active is Davis Todd C with $1000K.

Insiders

NameRoleRowsBoughtSoldLast filed
Friedberg Ezra MDirector12012October 6, 2026
Pauls MatthewDirector1005October 6, 2026
Greenleaf PeterDirector505October 6, 2026
Davis Todd CChief Executive Officer220July 6, 2026
Francis Knuettel IICFO, Treas & Secty402May 26, 2026
Malamut RichardDirector202April 6, 2026
Einhorn Andrew J.Director100December 29, 2025
LIGAND PHARMACEUTICALS INCDirector300December 19, 2025

Rows are this company's Form 4 rows for each person. "Bought" and "sold" count open-market purchases (code P) and sales only. More in insider buying and insider selling.

Insider transactions

Download CSV39 rows · 13 KB · insider and congressional rows for this ticker · all downloads

FilerSecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
Pauls MatthewPTHSSell SOctober 2, 2026October 6, 20264d786$21$17K10b5-1 planForm 4 ↗
Friedberg Ezra MPTHSSell SOctober 2, 2026October 6, 20264d558$21$12K10b5-1 planForm 4 ↗
Greenleaf PeterPTHSSell SOctober 2, 2026October 6, 20264d797$21$17K10b5-1 planForm 4 ↗
Friedberg Ezra MPTHSSell SJuly 2, 2026July 7, 20265d24$27$656late10b5-1 planForm 4 ↗
Friedberg Ezra MPTHSSell SJuly 2, 2026July 7, 20265d534$26$14Klate10b5-1 planForm 4 ↗
Pauls MatthewPTHSSell SJuly 2, 2026July 7, 20265d94$27$2,572late10b5-1 planForm 4 ↗
Pauls MatthewPTHSSell SJuly 2, 2026July 7, 20265d692$26$18Klate10b5-1 planForm 4 ↗
Greenleaf PeterPTHSSell SJuly 2, 2026July 7, 20265d85$27$2,318late10b5-1 planForm 4 ↗
Greenleaf PeterPTHSSell SJuly 2, 2026July 7, 20265d712$26$19Klate10b5-1 planForm 4 ↗
Friedberg Ezra MPTHSSell SJune 15, 2026June 17, 20262d59$28$1,64810b5-1 planForm 4 ↗
Friedberg Ezra MPTHSSell SJune 15, 2026June 17, 20262d224$27$6,07610b5-1 planForm 4 ↗
Davis Todd CPTHSBuy PJune 11, 2026June 15, 20264d503$29$14KForm 4 ↗
Davis Todd CPTHSBuy PJune 11, 2026June 15, 20264d35,445$28$986KForm 4 ↗
Francis Knuettel IIPTHSOption / conversion DMay 22, 2026May 26, 20264d42,500——derivativeForm 4 ↗
Francis Knuettel IIPTHSOther AMay 22, 2026May 26, 20264d59,500——derivativeForm 4 ↗
Francis Knuettel IIPTHSSell SMay 22, 2026May 26, 20264d1,500$27$40KindirectForm 4 ↗
Francis Knuettel IIPTHSSell DMay 22, 2026May 26, 20264d13,947——Form 4 ↗
Friedberg Ezra MPTHSSell FMay 14, 2026May 18, 20264d144$27$3,88910b5-1 planForm 4 ↗
Malamut RichardPTHSSell SApril 2, 2026April 6, 20264d280$21$5,98110b5-1 planForm 4 ↗
Malamut RichardPTHSSell SApril 2, 2026April 6, 20264d310$21$6,35910b5-1 planForm 4 ↗
Friedberg Ezra MPTHSSell SApril 2, 2026April 6, 20264d265$21$5,66110b5-1 planForm 4 ↗
Friedberg Ezra MPTHSSell SApril 2, 2026April 6, 20264d293$21$6,01010b5-1 planForm 4 ↗
Pauls MatthewPTHSSell SApril 2, 2026April 6, 20264d371$21$7,92610b5-1 planForm 4 ↗
Pauls MatthewPTHSSell SApril 2, 2026April 6, 20264d415$21$8,51410b5-1 planForm 4 ↗
Greenleaf PeterPTHSSell SApril 2, 2026April 6, 20264d377$21$8,05310b5-1 planForm 4 ↗
Greenleaf PeterPTHSSell SApril 2, 2026April 6, 20264d420$21$8,61610b5-1 planForm 4 ↗
Einhorn Andrew J.PTHSOther ADecember 23, 2025December 29, 20256d12,000——lateForm 4 ↗
LIGAND PHARMACEUTICALS INCPTHSOther ADecember 17, 2025December 19, 20252d———derivativeForm 4 ↗
LIGAND PHARMACEUTICALS INCPTHSOption / conversion DDecember 17, 2025December 19, 20252d———derivativeForm 4 ↗
Pauls MatthewPTHSOption / conversion MOctober 2, 2025December 12, 202571d2,123——latederivativeForm 4 ↗
Pauls MatthewPTHSOption / conversion MJuly 2, 2025December 12, 2025163d8,493——latederivativeForm 4 ↗
Pauls MatthewPTHSOther GDecember 10, 2025December 12, 20252d9,542——Form 4 ↗
Pauls MatthewPTHSOption / conversion MOctober 2, 2025December 12, 202571d2,123——lateForm 4 ↗
Pauls MatthewPTHSOption / conversion MJuly 2, 2025December 12, 2025163d8,493——lateForm 4 ↗
Friedberg Ezra MPTHSSell SNovember 25, 2025November 26, 20251d2,000$28$56KindirectForm 4 ↗
Friedberg Ezra MPTHSSell SNovember 25, 2025November 26, 20251d1$29$29indirectForm 4 ↗
Friedberg Ezra MPTHSSell SNovember 25, 2025November 26, 20251d2,000$28$56KindirectForm 4 ↗
Friedberg Ezra MPTHSSell SNovember 25, 2025November 26, 20251d5,999$28$168KindirectForm 4 ↗
LIGAND PHARMACEUTICALS INCPTHSOther ANovember 6, 2025November 10, 20254d—$9,000,000—derivativeForm 4 ↗

Federal contracts (USAspending, awards started in the last 180 days)

No contract award starting in the last 180 days was found for a recipient named exactly "Pelthos Therapeutics Inc.". Subsidiaries and differently-spelled recipients are not matched — search contracts.

Lobbying (Senate LDA, as client)

No LDA filing posted since October 2025 names "Pelthos Therapeutics Inc." as the client. Filings under a subsidiary or trade-association name are not matched — search lobbying.

Companies whose stock was traded by the same people who traded PTHS, by number of filers in common. It shows overlap in public filings and nothing else.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 41939November 10, 2025October 6, 2026Form 4 list on EDGAR

Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.

Not investment advice. Public records shown as filed; no recommendation is made or implied.